Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Start-Up Eidos Surfs Crest Of TTR Amyloidosis Wave

Aug 27 2018

• By Emily Hayes

Related Content

Pfizer Adds To Specialty Care Division With Purchase Of FoldRx

Sep 01 2010

Pfizer's Vyndaqel approved in Europe as first treatment for TTR-FAP

Nov 17 2011

The Next Roivant Or Fortress? BridgeBio Raises $135m To Spin Out New Companies

Sep 18 2017

Molecular Origami: Start-Ups Tackle Protein Folding

Dec 01 2006

Pfizer May Enjoy Blockbuster Cardiomyopathy Success With Tafamidis

Apr 02 2018

Alnylam Offers Flexible Value-Based Deals For Breakthrough RNAi Drug Onpattro

Aug 11 2018

Related Companies

Eidos Therapeutics, Inc.

BridgeBio Pharma, Inc.

Pfizer Inc.

Alnylam Pharmaceuticals Inc.

Akcea Therapeutics, Inc.

Ionis Pharmaceuticals, Inc.

Merck & Co., Inc.

Additional Topics

StartUps and SMEs Rare Diseases Companies Commercial Business Strategies BioPharmaceutical

More from Start-Ups & SMEs

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window